<DOC>
	<DOCNO>NCT02644915</DOCNO>
	<brief_summary>Ischemia-reperfusion ( I/R ) injury prominent cause delay graft function ( DGF ) kidney transplantation . Reactive oxygen specie play crucial role I/R injury . Edaravone synthetic radical scavenger use acute stroke . Some animal experiment reveal beneficial effect I/R injury , goal therefore investigate effectiveness recipient pretreatment Edaravone reduce occurrence DGF kidney transplantation .</brief_summary>
	<brief_title>Edaravone Ischemia-Reperfusion ( I/R ) Injury Kidney Transplantation Patients</brief_title>
	<detailed_description>Participants randomly assign , 1:1 ratio , receive Edaravone control ( 0.9 % Sodium Chloride Solution,0.9 % NaCl ) . The randomization sequence computer-generated , randomization perform block stratify accord participate center.Edaravone 0.9 % NaCl solution treat 10 minute kidney reperfusion , end 30 minute . The number dialysis serum creatinine level within first week transplantation record . The participation patient schedule 1 month .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Phenylmethylpyrazolone</mesh_term>
	<mesh_term>Antipyrine</mesh_term>
	<criteria>1 . ASAⅡⅢ , elective operation patient endstage renal disease 2 . Age 18yrs55yrs donor recipient 3. patient hemodialysis 4. severe complication history donor recipients 5. first kidney transplant recipient 6. patient write informed consent 1 . ASA Ⅳ 2. second renal transplant , multiorgan transplant dual kidney transplant 3. severe comorbidity history , example , severe cardiac dysfunction 4. cold ischemia time &gt; 24h warm ischemia time &gt; 45min 5. variation blood vessel ，operation time 2 hour 6. bleeding volume operation &gt; 500ml need blood transfusion 7. participate clinical trial 3 month enrollment 8. suitable participate experiment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>ischemia-reperfusion ( I/R ) injury</keyword>
	<keyword>Edaravone</keyword>
</DOC>